# CORCEPT THERAPEUTICS INC (CORT) FY2026 Q2 P&L / Income Statement

- Company: CORCEPT THERAPEUTICS INC (CORT)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0001628280-26-050613
- Page: https://plicit.ai/financials/cort/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/cort-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Product revenue, net**: 256,147,000 US dollars
- **Cost of sales**: 4,061,000 US dollars
- **Gross profit (calculated)**: 252,086,000 US dollars
- **Operating expenses (calculated)**: 210,786,000 US dollars
- **Income (loss) from operations**: 41,300,000 US dollars
- **Interest and other income**: 4,631,000 US dollars
- **Income before income taxes**: 45,931,000 US dollars
- **Income tax (expense) benefit**: 2,944,000 US dollars
- **Net income**: 42,987,000 US dollars
- **Hypercortisolism Products**: 208,583,000 US dollars
- **Lifyorli**: 47,564,000 US dollars
- **Research and development**: 53,890,000 US dollars
- **Selling, general and administrative**: 156,896,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.